(R)-Morpholin-2-ylmethanol hydrochloride is primarily utilized in pharmaceutical research and development as a chiral building block. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting neurological and cardiovascular disorders. Its chiral nature makes it valuable in the production of enantiomerically pure drugs, enhancing their efficacy and reducing potential side effects. Additionally, it is employed in the development of protease inhibitors and other therapeutic agents, contributing to advancements in medicinal chemistry.